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Abstract. 
 
During apoptosis, cytochrome c is released
into the cytosol as the outer membrane of mitochondria
becomes permeable, and this acts to trigger caspase ac-
tivation. The consequences of this release for mitochon-
drial metabolism are unclear. Using single-cell analysis,
we found that when caspase activity is inhibited, mito-
chondrial outer membrane permeabilization causes a
rapid depolarization of mitochondrial transmembrane
potential, which recovers to original levels over the
next 30–60 min and is then maintained. After outer
membrane permeabilization, mitochondria can use cy-
toplasmic cytochrome c to maintain mitochondrial trans-
membrane potential and ATP production. Furthermore,
both cytochrome c release and apoptosis proceed nor-
mally in cells in which mitochondria have been uncou-
pled. These studies demonstrate that cytochrome c re-
lease does not affect the integrity of the mitochondrial
inner membrane and that, in the absence of caspase ac-
tivation, mitochondrial functions can be maintained af-
ter the release of cytochrome c.
Key words: apoptosis • mitochondria • membrane
potential • caspases • ATP
 
Introduction
 
Apoptotic cell death is orchestrated by the activation of
caspase proteases that cleave key substrates within the cell
during the apoptotic process. A major pathway for caspase
activation involves a permeabilization of the mitochondrial
outer membrane, which releases several proteins, including
cytochrome c (Liu et al., 1996; Kluck et al., 1997), Smac/Di-
ablo (Du et al., 2000; Verhagen et al., 2000), and others
(Kluck et al., 1999; Kohler et al., 1999). Cytochrome c binds
and activates an adapter, the apoptotic protease activating
 
factor (Apaf)
 
1
 
-1, to recruit and activate caspase-9 (Li et al.,
 
1997; Srinivasula et al., 1998; Zou et al., 1999; Cain et al., 2000).
 
In mitochondria, cytochrome c plays an essential role
 
in generation of mitochondrial transmembrane potential
(
 
DC
 
m). This potential is essential for various functions in-
cluding the production of ATP via oxidative phosphoryla-
tion. Outer membrane permeability resulting in cytochrome
c release should therefore impact on mitochondrial function.
Proapoptotic and antiapoptotic Bcl-2 family proteins
regulate the mitochondrial outer membrane permeabiliza-
tion. However, the exact mechanism by which this event
occurs is controversial (for reviews see Gross et al., 1999;
Vander Heiden and Thompson, 1999; Waterhouse and
Green, 1999), and the various models that have been sug-
gested impact on mitochondrial function in different ways.
Cytochrome c release may proceed through the genera-
tion of pores or channels in the outer membrane, com-
posed all or in part of proapoptotic Bcl-2 family proteins
(Shimizu et al., 2000). Alternatively, it may occur through
disruption of the outer membrane after swelling of the mi-
tochondrial matrix due to opening of the permeability
transition pore (Marzo et al., 1998a,b; Brenner et al., 2000)
or as a consequence of a closure of the voltage-dependent
anion channels in the mitochondrial outer membrane
(Vander Heiden and Thompson, 1999; Vander Heiden et
al., 2000). In each case, however, the behavior and func-
tion of mitochondria should be affected, because the pro-
ton gradient generated by the electron transport chain
should be impaired. Disruption of the 
 
DC
 
m may even kill
a cell if downstream apoptotic effects are blocked. Such
Bcl-2–regulated, caspase-independent cell death has been
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 Apaf, apoptotic protease activat-
ing factor; CCCP, carbonyl cyanide m-chlorophenylhydrazone; Cc-
GFP-HeLa, HeLa cells stably expressing GFP-tagged cytochrome c;
CLAMI, cell lysis and mitochondria intact; DNP, dinitrophenol, 
 
DC
 
m,
 
mitochondrial transmembrane potential; FCCP, carbonyl cyanide
 
p
 
-(trifluoromethoxy) phenylhydrazone; GFP, green fluorescent pro-
tein; MIB, mitochondria isolation buffer; tBid, truncated Bid;
 
 
 
TMRE,
tetramethylrhodamine ethyl ester; zVADfmk, 
 
N
 
-benzoylcarbonyl-Val-
Ala-Asp-fluoromethylketone. 
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described (McCarthy et al., 1997; Martinou et al., 1999;
Deshmukh et al., 2000; Haraguchi et al., 2000).
Mitochondrial function may therefore impact on the
death of a cell in several ways. Altered 
 
DC
 
m may lead to
cytochrome c release and activation of caspases or con-
versely cytochrome c release may alter mitochondrial
function, which in the absence of caspase activity may lead
to the death of the cell. Here, we take advantage of single-
cell analysis to follow changes in the mitochondrial trans-
membrane potential in relation to mitochondrial outer
membrane permeabilization in cells triggered to undergo
apoptosis after toxic insults. We observed that a reduction
in 
 
DC
 
m followed within minutes after the release of cyto-
chrome c. We found, however, that in the absence of
caspase activity mitochondria use, cytochrome c at the
concentration maintained within the cytoplasm to regen-
erate 
 
DC
 
m and maintain ATP generation.
 
Materials and Methods
 
Cell Culture
 
HeLa cells stably expressing green fluorescent protein (GFP)–tagged cy-
tochrome c (Cc-GFP-HeLa) (Goldstein et al., 2000), Cc-GFP-HeLa cells
expressing Bcl-2 and murine embryonic fibroblasts deficient in Apaf-1 (a
gift from Dr. F. Cecconi, University of Rome, Rome, Italy) were cultured
in DME (GIBCO BRL), and Jurkat cells were grown in RPMI-1640
(GIBCO BRL). All cell lines were maintained at 37
 
8
 
C in a humidified at-
mosphere of 95% air, 5% CO
 
2
 
,
 
 
 
and all media were supplemented with 2
mM glutamine, 200 
 
m
 
g/ml penicillin, 100 
 
m
 
g/ml streptomycin sulphate, and
10% FBS. Adherent cells were subcultured 1:10 by incubating them in
0.25% trypsin (GIBCO BRL) when they were 70% confluent, and resus-
pending cells were subcultured in growth medium. Suspension cells were
subcultured 1:10 when they reached 10
 
6
 
 cells/ml.
To induce death, Cc-GFP-HeLa cells were treated with actinomycin D
(1 
 
m
 
M), staurosporine (1 
 
m
 
M), or UVC ultraviolet C (180 mJ/cm
 
2
 
). For
UV treatment, cells were washed in PBS and irradiated with UV light in
PBS at 37
 
8
 
C. The PBS was then aspirated, and the media were replaced.
Apaf
 
2/2
 
 cells were treated with actinomycin (1 
 
m
 
M), and Jurkat cells were
treated with actinomycin D (500 nM), staurosporine (500 nM), or etopo-
side (40 
 
m
 
M). In experiments where glucose-free medium was used, the
cells were washed once with serum-free, glucose-free DME and cultured
for 12–15 h in DME containing 10% FBS dialyzed against PBS.
 
Detection of Apoptotic Events by Flow Cytometry
 
Cells having undergone specific apoptotic events were detected by flow
cytometry using a FACScan
 
®
 
 (Becton Dickinson) with a 488-nm laser line
and analyzed using Cell Quest software. Phosphatidylserine exposed on
the outside of cells was determined by annexin V binding. In brief, cells
were pelleted and resuspended in 100 
 
m
 
l of Annexin V-FITC (Calbio-
chem) diluted 1:100 in annexin buffer (10 mM Hepes, 100 mM NaCl, 10
mM KCl, 1 mM MgCl
 
2
 
, 1.8 mM CaCl
 
2
 
). Cells were incubated for 5 min at
37
 
8
 
C, and 200 
 
m
 
l annexin buffer containing propidium iodide (0.5 
 
m
 
g/ml)
was added before FACS
 
®
 
 analysis. Annexin V-FITC fluorescence was de-
tected in FL-1, and propidium iodide was detected in FL-2.
Cytochrome c release was detected by incubating 4
 
 3 
 
10
 
4
 
 Cc-GFP-
HeLa cells in 100 
 
m
 
l of ice-cold cell lysis and mitochondria intact
(CLAMI) buffer (250 mM sucrose, 70 mM, KCl 50 
 
m
 
g/ml digitonin in
PBS) for 5 min. Aliquots from the suspensions were stained with 0.1% Try-
pan blue in PBS to ensure that 
 
.
 
95% of the cells were lysed. 200 
 
m
 
l of ice-
cold digitonin-free CLAMI buffer was added to the cell suspension, and the
cells were measured immediately by flow cytometry. Cytochrome c–GFP
fluorescence was detected in FL-1. At the concentration used here, digito-
nin selectively permeabilizes the plasma membrane, allowing any cyto-
chrome c that has been released from the mitochondria to exit the cells. The
fluorescence of cells with intact mitochondria was approximately one-third
brighter than cells in which the mitochondria had released cytochrome c.
 
DC
 
m was measured primarily using tetramethylrhodamine ethyl ester
(TMRE). Cells were incubated at 37
 
8
 
C for 20 min in media containing
TMRE (50 nM). TMRE fluorescence was detected by flow cytometry us-
 
ing FL-2. 
 
DC
 
m was also measured using DiOC
 
(6)
 
3 (40 nM), and CMTM-
Ros (150 nM) also diluted in media.
 
Western Blotting
 
To determine the extent of cytochrome c release in cells by western blot-
ting, 1.5 
 
3
 
 10
 
6
 
 Jurkat cells were incubated on ice for 5 min in 100 
 
m
 
l of ice-
cold CLAMI buffer containing 200 
 
m
 
g/ml digitonin. The lysis of 
 
.
 
95% of
the cells was confirmed by Trypan blue exclusion. The cells were pelleted
(1,000 
 
g
 
 for 5 min at 4
 
8
 
C), and the supernatant containing cytosolic protein
was stored at 
 
2
 
80
 
8
 
C. The pellets were incubated at 4
 
8
 
C for 10 min in uni-
versal immunoprecipitation buffer (50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 2 mM EDTA, 2 mM EGTA, 0.2% Triton X-100, 0.3% NP-40 1
 
3
 
complete™ protease inhibitor (Roche). The samples were centrifuged
(10,000
 
 g
 
 for 10 min at 4
 
8
 
C), and the supernatant containing mitochondrial
protein was stored at 
 
2
 
80
 
8
 
C. Protein from each sample were boiled for 5
min in 5
 
3
 
 sample loading buffer and electrophoresed in individual lanes
of 15% SDS-PAGE gels. The proteins were transferred to supported Hy-
bond C nitrocellulose (Amersham Pharmacia Biotech) and Western blot-
ted using anti–cytochrome c (7H8.2C12; PharMingen) and antiactin (C4;
ICN Biomedicals) diluted 1:1,000. The immobilized proteins were incu-
bated with horseradish peroxidase secondary antibody, and the signal was
detected using Dura Signal chemiluminescence reagent (Pierce Chemical
Co.).
 
Confocal Microscopy
 
Confocal microscopy was performed using a Nikon Eclipse TE 300 micro-
scope and a MRC 1024 confocal microscope (Bio-Rad Laboratories) us-
ing an Ar/Kr laser. For immunocytochemistry, Cc-GFP-HeLa cells were
grown on LabTek four-well chamber slides (Nalge Nunc International).
Cells were fixed with 4% paraformaldehyde in PBS for 15 min. The cells
were washed in blocking buffer (0.05% saponin, 3% BSA, in PBS) and in-
cubated overnight at 4
 
8
 
C with anti-Bax antibody (PharMingen) diluted
1:200 in blocking buffer. The cells were washed in blocking buffer and in-
cubated for 1 h at room temperature with rabbit Ig conjugated to Texas
red (Amersham Pharmacia Biotech) diluted 1:200 in blocking buffer. The
fluorescence of GFP and Texas red were detected by confocal microscopy
using excitation wavelengths of 488 or 522 nm and detection wavelengths
of 568 or 605 nm, respectively. Images were Kalman averaged.
For time-lapse analysis, Cc-GFP-HeLa cells were grown on glass-bot-
tom microwell dishes (MatTek). Cells were treated with apoptotic stimuli
in phenol red–free DME, supplemented with 10% FBS, 20 mM Hepes,
pH 7.2, 2 mM 
 
L
 
-glutamine, 200 
 
m
 
g/ml penicillin, 100 
 
m
 
g/ml streptomycin
sulphate, and TMRE (50 nM), and returned to an incubator for 2–12 h.
The media were overlaid with mineral oil (Sav-On), and the dish was
placed on the confocal microscope. The temperature was maintained at
37
 
8
 
C using an MS-C Temp Controller (Narishige). Cells were excited us-
ing a 488-nm laser line attenuated at 96%. Cytochrome c–GFP and
TMRE fluorescence were detected using 568 or 605 nm, respectively. Im-
ages were Kalman averaged three times each at 2-min intervals. Un-
treated cells followed under these conditions for 400 frames were undam-
aged, to the extent that mitosis was observed in many cells during this
period.
Images were analyzed with Metamorph v4.0 (Universal Imaging Corp.)
by drawing regions around individual cells and then computing standard
deviation (punctate/diffuse) and integrated brightness (total brightness).
For 
 
DC
 
m, the total brightness of TMRE was divided by the total bright-
ness of the cytochrome c–GFP to account for any movement of the cell,
except in Apaf-deficient murine embryonic fibroblasts, which contained
no cytochrome c–GFP. The punctate–diffuse index and the relative
TMRE fluorescence index were calculated by dividing each value by the
average of the first six values. In Fig. 3 C, the relative TMRE fluorescence
of each cell was calculated by dividing each value by the average of the
first 119 values. Quicktime movies were processed using NIH Image J
software (National Institutes of Health).
 
Measurement of Cellular ATP
 
ATP assays were performed using the ATP bioluminescence assay kit
HSII (Roche) following the manufacturer’s instructions. In brief, 10
 
5
 
 cells
were resuspended in 100 
 
m
 
l lysis buffer and stored at 
 
2
 
80
 
8
 
C. Aliquots
from each sample were diluted to 100 
 
m
 
l in dilution buffer. 100 
 
m
 
l of lu-
ciferase reagent was added to each sample and after a delay of 1 s, the lu-
minescence was integrated over 10 s using a monolight 2010 luminescence
recorder (Analytical Luminescence Laboratory). The ATP concentration 
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of the samples was determined by comparing values to a standard curve
for ATP performed at the same time. The ATP concentration was stan-
dardized using the total cellular protein estimated by the micro BCA as-
say (Pierce Chemical Co.).
 
Permeabilized Cell Assays for 
 
DC
 
m
 
Cc-GFP-HeLa cells (2 
 
3 
 
10
 
6
 
) were incubated for 20 min at 37
 
8
 
C in media
containing TMRE (50 nM). Buffers in all subsequent steps contained
TMRE (50 nM). The cells were trypsinized and incubated for 5 min on ice
in 1 ml of ice-cold mitochondria isolation buffer (MIB) (200 mM manni-
tol, 50 mM sucrose, 10 mM Hepes, 10 mM succinate, 70 mM KCl, 1 mM
DTT) containing 50 
 
m
 
g/ml digitonin. When 
 
.
 
95% of cells were perme-
able to Trypan blue, the cells were washed twice in ice-cold MIB contain-
ing 0.1% BSA. For Fig. 2 A, the cells were incubated for 30 min at 37
 
8
 
C in
1 ml of MIB containing truncated Bid (tBid) (20 
 
m
 
g/ml) and diluted in 1:10
in MIB containing BSA (0.1%) ATP (1 mM), creatin-phosphate (5 mM),
creatin kinase (0.1 mg/ml), oligomycin (10 
 
m
 
g/ml), and the concentrations
of cytochrome c indicated. Carbonyl cyanide 
 
p
 
-(trifluoromethoxy) phe-
nylhydrazone (FCCP) (10 
 
m
 
M) and KCN (1 mM) were added as indi-
cated. The cells were analyzed by flow cytometry after 20 min, measuring
cytochrome c–GFP fluorescence in FL-1 and TMRE fluorescence in FL-2.
Analysis confirmed that 
 
.
 
95% of cells treated with tBid had released cy-
tochrome c–GFP. For Fig. 2 B, the permeabilized apoptotic cells were di-
rectly resuspended in the MIB containing cytochrome c, and the cells
were analyzed by flow cytometry after 20 min.
 
Online Supplemental Material
 
Supplemental video of Fig. 4 shows loss and regeneration of 
 
DC
 
m after
cytochrome c release. Cc-GFP-HeLa cells were treated with actinomycin
D (1 
 
m
 
M) in the presence of 
 
N
 
-benzoylcarbonyl-Val-Ala-Asp-fluoro-
methylketone (zVADfmk) (100 
 
m
 
M), and confocal images were taken ev-
ery 2 min. The cytochrome c–GFP (green, left) shows the coordinate re-
lease of cytochrome c in the individual cells (the staining goes from
punctate to diffuse upon release). TMRE fluorescence in the same cells
(red, right) shows the loss and recovery of 
 
DC
 
m. The red and green im-
ages are of the same cells taken at the same time. The frames are separate
rather than overlaid for clarity, and a mathematical representation of loss
and regeneration of 
 
DC
 
m in a similarly treated cell is shown in Fig. 4 A.
Video is available at http://www.jcb.org/cgi/content/full/153/2/319/DC1.
 
Results
 
Cytochrome c Maintains 
 
DC
 
m after Mitochondrial 
Outer Membrane Permeabilization
 
To examine the relationship between 
 
DC
 
m and the per-
meabilization of the outer mitochondrial membrane, we
took advantage of a recently described HeLa cell line (Cc-
GFP-HeLa) stably expressing cytochrome c–GFP in the
mitochondrial intermembrane space (Goldstein et al.,
2000). In these cells, the release of cytochrome c–GFP
faithfully mirrors the release of cytochrome c, and this oc-
curs in a kinetically rapid all-or-nothing manner during ap-
optosis. We monitored 
 
DC
 
m using TMRE, which incorpo-
rates into the mitochondria in a nernstian manner in
relation to 
 
DC
 
m (Farkas et al., 1989; Fink et al., 1998).
Previously, we have found that in CEM and HeLa cells
treated with UV radiation in the presence of the caspase
inhibitor zVADfmk, cytochrome c can be released without
significantly affecting 
 
DC
 
m (Bossy-Wetzel et al., 1998). To
confirm this finding in the cell lines used in the this study,
we treated Jurkat or Cc-GFP-HeLa cells with actinomycin
D, staurosporine, UV, or etoposide and examined 
 
DC
 
m
by TMRE staining. As shown in Fig. 1, loss of 
 
DC
 
m in Jur-
kat cells treated with etoposide or Cc-GFP-HeLa cells
treated with actinomycin D was prevented by addition of
the caspase inhibitor. Similar results were obtained in both
cell lines treated with staurosporine and in Cc-GFP-HeLa
cells treated with UV (data not shown), and when other
dyes including CMTM-ROS and DiOC
 
(6)
 
3 were used to
Figure 1. Loss of DCm is caspase dependent during apoptosis. (A)
Jurkat cells treated with etoposide (40 mM) or Cc-GFP-HeLa cells
were treated with actinomycin D (1 mM) in the presence or ab-
sence of zVADfmk (100 mM), harvested at the times indicated,
stained with TMRE (50 nM), and analyzed by flow cytometry.
Low fluorescence indicates a loss of DCm. (B) A representation
of A, in which untreated cells (thin lines) are overlaid directly on
cells treated with the apoptosis inducer in the presence of
zVADfmk (zVAD) (100 mM). In the Cc-GFP-Hela cells, 57% of
cells had released cytochrome c–GFP by this point.
Figure 2. Cytochrome c concentration limits respiration in mito-
chondria that have undergone outer membrane permeabiliza-
tion. (A) Permeabilized cells stained with TMRE (50 nM), either
untreated or treated with tBid, were incubated at 378C for 20
min with the concentrations of horse heart cytochrome c indi-
cated. DCm was measured by flow cytometry. FCCP (10 mM)
was used as a control for depolarized mitochondria. KCN (1
mM) was used to block the involvement of cytochrome c in the
electron transport chain. (B) Cc-GFP-HeLa cells were treated
for 12 h with actinomycin D (1 mM) and stained with TMRE (50
nM). The cells were permeabilized with digitonin and incubated
for 20 min with horse heart cytochrome c. DCm and cytochrome
c–GFP were measured by flow cytometry. The cells were gated
for cytochrome c–GFP release, and the relative fluorescence of
TMRE was compared with that of cells that had not released
cytochrome c–GFP. Error bars indicate SD. 
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measure 
 
DC
 
m (not shown). In every case, zVADfmk did
not affect cytochrome c release in Cc-GFP-HeLa cells
(Goldstein et al., 2000).
The maintenance of 
 
DC
 
m may be through either the
electron transport chain or through ATP-dependent re-
versal of ATP synthase (Simbula et al., 1997). We have
previously shown that oligomycin, an ATP synthase inhib-
itor, does not dissipate the 
 
DC
 
m maintained after cyto-
chrome c release, whereas inhibitors of complex III (which
donates electrons to cytochrome c) and complex IV
(which accepts electrons from cytochrome c) do (Gold-
stein et al., 2000). This suggested that cytochrome c that is
still present in the cell after its release from mitochondria
is sufficient to maintain electron transport and 
 
DC
 
m.
To test this idea, we induced the release of intermem-
brane proteins from mitochondria in digitonin-permeabi-
lized cells, using recombinant tBid to mimic the apoptotic
process (von Ahsen et al., 2000). As shown in Fig. 2 A,
treatment with tBid caused a rapid loss of 
 
DC
 
m, to the
same extent produced by the protonophore FCCP. Upon
addition of cytochrome c, however, 
 
DC
 
m was maintained,
despite the presence of oligomycin to block the generation
of 
 
DC
 
m by hydrolysis of ATP. 
 
DC
 
m was not maintained in
the presence of the complex IV inhibitor KCN. Thus, the
loss of 
 
DC
 
m was due to the release of cytochrome c and
not other mitochondrial changes.
Then, we examined the role of cytochrome c in main-
taining 
 
DC
 
m in cells induced to undergo apoptosis in the
presence of caspase inhibitors. Cc-GFP-HeLa cells were
treated with actinomycin D plus zVADfmk, and cyto-
chrome c–GFP release was monitored (not shown). At a
time point when the majority of cells exhibited cyto-
chrome c–GFP release, the cells were treated with digito-
 
nin to permeabilize the plasma membrane. This resulted in
a complete loss of 
 
DC
 
m (Fig. 2 B) as all available cy-
tochrome c was washed free. Addition of exogenous cy-
tochrome c significantly restored DCm in these cells.
Therefore, the outer membranes of mitochondria in per-
meabilized tBid-treated or apoptotic cells are permeable
to cytochrome c, which can restore electron transport in
these mitochondria. It follows that the maintenance of
DCm after mitochondrial outer membrane permeabiliza-
tion is through the use of the low levels of cytosolic cyto-
chrome c. By comparing the total amount of cytochrome c
in these cells with standard concentrations of horse heart
cytochrome c in immunoblots, we estimated that if cyto-
chrome c were evenly dispersed throughout the cell, it
would be z10 mM (not shown). Addition of 10 mM cyto-
chrome c in our permeabilized cell assays was sufficient to
maintain the DCm (Fig. 2 A).
Analysis of Single Cells Undergoing Apoptosis Shows a 
Drop and Recovery of DCm after Cytochrome
c–GFP Release
Competing models that explain the permeabilization of the
mitochondrial outer membrane make different predictions
regarding changes in DCm before the release of cyto-
chrome c. Outer membrane rupture after permeability tran-
sition (Marzo et al., 1998b) or closure of the voltage-depen-
dent anion channels (Vander Heiden and Thompson, 1999)
involve dissipation or increase in DCm, respectively.
In time-lapse confocal microscopy experiments, we con-
sistently observed that, upon addition of the protonophore
FCCP, TMRE staining was lost in ,2 min. At the concen-
tration used, TMRE did not suffer from self-quenching as-
Figure 3. Time course analy-
sis of DCm during apoptosis.
Cc-GFP-HeLa cells stained
with TMRE and treated with
actinomycin D (1 mM) in the
presence (1zVAD) or absence
(2zVAD) of 100 mM zVAD-
fmk as indicated, and were fol-
lowed by time-lapse confocal
microscopy. Images were
taken every 2 min and the rela-
tive brightness of TMRE fluo-
rescence and punctate–diffuse
index of cytochrome c–GFP
was calculated and plotted
over time. (A) Two cells,
which commenced cytochrome
c–GFP release at 534 and 474
min show a subsequent drop in
DCm, commencing at 536 and
478 min, respectively. (B) Sim-
ilar cells in the absence or
presence of zVADfmk (100
mM) were followed by time-
lapse confocal microscopy, and
the relative brightness of
TMRE fluorescence was calcu-
lated and plotted over time. For comparative purposes, cytochrome c–GFP
release (indicated by arrow) was set at 4 h in each case. (C) The mean bright-
ness of TMRE in individual cells aligned for cytochrome c release at 4 h. n
represents the number of cells averaged. Error bars indicate SD.Waterhouse et al. Mitochondrial Function in Apoptosis 323
sociated with other dyes used to track DCm and did not af-
fect mitochondrial function or cell viability (data not
shown). We therefore used TMRE fluorescence to track
DCm in individual Cc-GFP-HeLa cells after treatment with
actinomycin D, UV, or staurosporine. As shown in several
examples depicted in Fig. 3, A and B, DCm was never seen
to dissipate before cytochrome c–GFP release, although in
some cases an increase was observed (Fig. 3 B). When indi-
vidual cells treated with actinomycin D in the presence or
absence of zVADfmk were standardized for cytochrome
c–GFP release at 4 h, the mean DCm showed that there
were no significant or consistent changes before mitochon-
drial outer membrane permeabilization (Fig. 3 C).
Dissipation of DCm commenced shortly after cyto-
chrome c release (Fig. 3 A). Previously, we observed that
reducing the temperature by 138C did not influence the
duration of cytochrome c release (Goldstein et al., 2000).
Using the relative TMRE fluorescence in individual cells
treated with actinomycin D plus zVADfmk, we observed
that the duration of DCm loss (the time taken to reduce
DCm from its value at the time cytochrome c–GFP was re-
leased until DCm was ,10% of its lowest value before cy-
tochrome c–GFP release) increased from 11.9 6 2.7 min at
378C (n 5 43) to 33.2 6 7.3 min at 248C (n 5 16). This was
not due to the time required for diffusion of TMRE from
the depolarized mitochondria, as FCCP caused a complete
loss of staining in ,2 min at either temperature (data not
shown).
Strikingly, however, upon the release of cytochrome c,
DCm rapidly decreased in all cases, whether or not zVAD-
fmk was present. Therefore, the single-cell analysis appeared
to directly contradict our bulk level observations in Fig. 1.
Figure 4. Dissipation and
regeneration of DCm after
cytochrome c release in the
absence of caspases. (A)
Time lapse of the relative
brightness of TMRE and
the punctate–diffuse index
of cytochrome c–GFP in
one Cc-GFP-HeLa cell
treated with actinomycin D
(1 mM) in the presence of
zVADfmk showing a drop
in  DCm, followed by a slow
regeneration of DCm after
cytochrome c–GFP release.
Cytochrome c–GFP release
was set at 120 min. (B) Pic-
tographic representation of
DCm and cytochrome c–GFP
in the cell depicted in A shows
that  DCm is regenerated,
whereas cytochrome c–GFP
remains diffuse throughout
the cell. More cells can be
seen in Quicktime movie
format at http://www.jcb.org/
cgi/content/full/153/2/319/DC1.
In the movie, green (left) in-
dicates cytochrome c–GFP,
whereas red (right) indicates
TMRE staining. (C and D)
Time-lapse of the relative
brightness of TMRE fluores-
cence of one Apaf-1–defi-
cient murine embryonic fi-
broblast (apaf-deficient MEF)
treated with 1 mM actino-
mycin D (C), one Cc-GFP-
HeLa cell treated with 1 mM
staurosporine in the pres-
ence of 100 mM zVADfmk
(Di), or one Cc-GFP-HeLa
cell treated with 1 mM stau-
rosporine in the presence of
100  mM zVADfmk and 10
mg/ml of oligomycin (Dii).
Bars, 10 mm.The Journal of Cell Biology, Volume 153, 2001 324
Careful observations over time, though, resolved this appar-
ent paradox. As shown in Fig. 4 A, after the drop in DCm
upon cytochrome c release in cells treated with actinomycin
D plus zVADfmk, DCm recovered over the next 30–60 min
and remained high (until accumulated visual light damage
due to repeated assessments eventually reduced DCm).
The images in Fig. 4 B show the fluorescence in this cell
over time, clearly demonstrating the loss and recovery of
TMRE staining after cytochrome c release. Therefore, the
observations on cell populations in Fig. 1 represent cells in
which the large majority of those that have released cyto-
chrome c have already recovered DCm.
The loss and recovery of DCm was not due to the pres-
ence of Cc-GFP, since a similar effect was seen in HeLa
cells that did not express Cc-GFP (not shown), nor was it
dependent on the use of caspase inhibitors, as a similar
loss and recovery in DCm was observed in a transformed
cell line from Apaf-1–deficient murine embryonic fibro-
blasts treated with actinomycin D (Fig. 4 C). Furthermore,
this effect was not restricted to apoptosis induced by acti-
nomycin D and was not dependent on the function of com-
plex V (which, as we noted, could maintain transmem-
brane potential by hydrolyzing ATP), since both drop and
recovery of DCm occurred in cells treated with staurospo-
rine plus zVADfmk in the presence or absence of oligo-
mycin (Fig. 4 D). Similarly, cyclosporin A, which inter-
feres with the mitochondrial permeability transition, had
no effect at doses up to 400 mM on either the drop or re-
covery phases after cytochrome c release (not shown).
Therefore, this is not an effect of a reversible permeability
transition observed as a flicker, i.e., a rapid decrease and
increase of fluorescence of dyes used to measure DCm
(Huser and Blatter, 1999; Ichas et al., 1997).
One of the major functions of the electron transport
chain is to generate ATP via complex V. If, after the perme-
abilization of the outer membrane, the mitochondria can
use the decreased amounts of cytochrome c to sustain elec-
tron transport, then ATP levels should be maintained. We
therefore examined ATP levels in Cc-GFP-HeLa cells de-
prived of glucose and provided with pyruvate to ensure that
the majority of ATP generation was dependent on mito-
chondrial electron transport and the function of complex V.
Consistent with our hypothesis, we noted a decrease in ATP
levels in the glucose-deprived cells upon treatment with oli-
gomycin for 1 h (indicated by the dashed lines in Fig. 5 Aiii),
and the majority of cells died within 12 h (not shown). In
the presence of glucose, Cc-GFP-HeLa cells were resistant
to oligomycin-induced death for .3 d (not shown).
When the glucose-deprived cells were induced to un-
dergo mitochondrial outer membrane permeabilization by
treatment with actinomycin D (6zVADfmk),  z80% of
the cells released cytochrome c–GFP after 12 h (Fig. 5
Aii). ATP levels were reduced in the absence of zVAD-
fmk, however, in the presence of zVADfmk, DCm (Fig. 5 ,
Ai and Aii) and ATP levels were maintained (Fig. 5, Aiii
and B). Therefore, the maintenance of DCm provided
enough electromotive force to maintain ATP generation,
despite the low levels of cytochrome c available. This ef-
fect was only temporary, however, since ATP levels
dropped over the after 12 h, and extensive nonapoptotic
death was observed after 24 h under these conditions (not
shown). We further confirmed the ability of mitochondria
to generate ATP under these conditions by treating Cc-
GFP-HeLa cells with actinomycin D in the presence or ab-
sence of zVADfmk. After 12 h, when permeabilization of
the outer mitochondrial membrane had occurred in z80%
of the cells, oligomycin was added to cells that were
treated in the presence of zVADfmk. After 1 h, the cells
were harvested, and total cellular ATP levels were mea-
sured. ATP levels were significantly lower in the treated
cells compared with those in control cells, unless caspase
activation was blocked by zVADfmk. (Fig. 5 B). The addi-
tion of oligomycin for 1 h caused a loss of ATP even in the
presence of zVADfmk. Therefore, ATP levels were main-
tained by mitochondrial complex V function in these cells.
These data strongly support the conclusion that most
mitochondria remain functional after the permeabilization
of the outer mitochondrial membrane using the reduced
levels of available cytochrome c now diffuse through the
cytosol. Upon caspase activation, this effect is lost, and
ATP levels then decrease dramatically. The loss of mi-
tochondrial function and drop in ATP correspond to
caspase-independent death of the cells.
Figure 5. Mitochondria that maintain DCm after cytochrome c
release also produce ATP. (A) Cc-GFP-HeLa cells cultured in
the absence of glucose for 12–15 h were treated with actinomycin
D (1 mM) in the presence or absence of zVADfmk (100 mM).
(Ai) After 12 h, the cells were stained with TMRE (50 nM) and
analyzed by flow cytometry. Cells treated in the presence of
zVADfmk, maintained DCm. (Aii) Similarly treated cells were
harvested at the times indicated and percentage of cells with polar-
ized mitochondria, and the percentage of cells that had not released
cytochrome c were determined by flow cytometry. (Aiii) Aliquots
of cells in Aii were analyzed for total cellular ATP. (B) Cc-GFP-
HeLa cells cultured in the absence of glucose for 12–15 h were
treated with actinomycin D (1 mM) in the presence or absence of
zVADfmk (100 mM). After 12 h, when z80% of the cells had re-
leased cytochrome c, oligomycin (10 mg/ml) was added to the
sample indicated. All cells were harvested 1 h later, and total
cellular ATP was measured. Error bars indicate SEM.Waterhouse et al. Mitochondrial Function in Apoptosis 325
Mitochondrial Transmembrane Potential Is Not 
Required for Apoptosis, Mitochondrial Outer 
Membrane Permeabilization, or the Antiapoptotic 
Effects of Bcl-2
The mitochondrial transmembrane potential, maintained
by the low level of cytochrome c in apoptotic cells before
caspase activation, is required for several mitochondrial
functions, including the maintenance of ATP generation,
as noted above. Therefore, we determined whether this
was also required for the mitochondrial changes that func-
tion to promote or prevent apoptosis.
Uncouplers such as FCCP, carbonyl cyanide m-chlo-
rophenylhydrazone (CCCP), and 2,4, dinitrophenol (DNP)
dissipate the transmembrane potential by preventing the
generation of a proton gradient. We examined the effects
of FCCP on cytochrome c release and apoptosis in Jurkat
cells and Cc-GFP-HeLa cells treated with various inducers
of apoptosis. In no case did dissipation of the transmem-
brane potential block, diminish, or delay cytochrome c re-
lease or apoptosis and often slightly increased sensitivity
to proapoptotic agents (Fig. 6). Similar results were ob-
served when CCCP or DNP were used in place of FCCP
(data not shown).
The proapoptotic Bcl-2 family members tBid and Bax
can translocate to the mitochondria during apoptosis and
effectively and rapidly trigger mitochondrial outer mem-
brane permeabilization (von Ahsen et al., 2000; Wei et
al., 2000). Immunocytochemistry of Cc-GFP-HeLa cells
treated with UV (Fig. 7 A) or actinomycin D (not shown)
revealed that Bax had translocated to the mitochondria of
all cells in which cytochrome c–GFP was in the cytoplasm.
Furthermore, the addition of recombinant tBid or Bax to
digitonin-permeabilized Cc-GFP-HeLa cells resulted in
loss of green fluorescence, indicative of the release of cyto-
chrome c–GFP from mitochondria (Fig. 7 B). Dissipation
of the mitochondrial transmembrane potential with FCCP
had no effect on the ability of these proapoptotic Bcl-2
family proteins to permeabilize the mitochondrial outer
membrane (Fig. 7 B). Furthermore, Bax overexpressed in
Cc-GFP-HeLa treated with FCCP induced cytochrome
c–GFP release in a similar number of cells as compared
with control cells (not shown).
Figure 6. Apoptosis and cy-
tochrome c release proceed
in the absence of hyperpolar-
ization. (A) Jurkat cells were
treated with etoposide (40
mM) or actinomycin D (500
nM), and Cc-GFP-HeLa
cells were treated with UV
(180 mJ/cm2) or actinomycin
D (1 mM) in the presence or
absence of FCCP (5 mM) for
the times indicated. The cells
were analyzed for phosphati-
dylserine exposure as a mea-
sure of apoptosis. (B) Similar
cells to those assayed in A
were analyzed for cyto-
chrome c release (Bi) by
western blotting (Jurkat) or
cytochrome c–GFP release
(Bii) by flow cytometry (Cc-
GFP-HeLa). (C) Untreated
Cc-GFP-HeLa cells or Cc-
GFP-HeLa cells treated with
UV (180 mJ/cm2) in the
presence or absence of the
concentrations of FCCP in-
dicated were harvested at 6 h
and assayed for phosphati-
dylserine exposure (an-
nexin V-FITC binding) or
cytochrome c–GFP release
(CLAMI assay) by flow cy-
tometry.The Journal of Cell Biology, Volume 153, 2001 326
Bcl-2 functions to inhibit or delay apoptosis, at least in
part, by preventing mitochondrial outer membrane per-
meabilization (Kluck et al., 1997; Yang et al., 1997). Cyto-
chrome c release and apoptosis are effectively blocked in
Cc-GFP-HeLa cells that stably express Bcl-2 (Fig. 7 C).
Dissipation of the mitochondrial transmembrane potential
by FCCP, CCCP, or DNP did not alter this protective
mechanism of Bcl-2. Therefore, the maintenance of DCm
is not required for either the proapoptotic or antiapoptotic
effects of Bcl-2 family members and is not required for ei-
ther mitochondrial outer membrane permeabilization or
apoptosis after cellular stress.
We conclude that the most important functions of the
maintenance of DCm after mitochondrial outer mem-
brane permeabilization are to provide a continued source
of energy to the cell and to maintain mitochondrial func-
tions if the apoptotic pathway is blocked downstream of
this event. This raises the possibility that mitochondrial re-
pair and cell survival might be possible after this potential
point-of-no-return in the apoptotic process.
Discussion
Permeabilization of the mitochondrial outer mitochon-
drial membrane, regulated by Bcl-2 family members, is an
integral event during apoptosis. Upon permeabilization,
cytochrome c is released to facilitate formation of the ap-
optosome and caspase activation. The mechanism of outer
membrane permeabilization remains controversial, and
the consequences of this event on mitochondrial and cellu-
lar metabolism—other than activation of caspases—are
not well understood. In this paper, we have shown that af-
ter the permeabilization of the mitochondrial outer mem-
brane, DCm transiently decreases. When caspase activa-
tion is blocked, DCm then recovers and is maintained by
the low levels of cytochrome c diffuse throughout the cell.
In cells that have released cytochrome c in the absence of
caspase activation, the maintenance of DCm is sufficient
for the mitochondria to generate ATP.
Several hypotheses for the mechanism of mitochondrial
outer membrane permeabilization predict an increase (hy-
perpolarization) or decrease (permeability transition) in
DCm before the permeabilization event. However, in sin-
gle-cell analysis, using cytochrome c–GFP as an indicator
of mitochondrial outer membrane permeabilization and
TMRE to follow DCm, we never observed a loss of DCm
before cytochrome c release (Fig. 3). Similarly, hyperpo-
larization did not occur uniformly before cytochrome c re-
lease and was only observed in a small subset of cells. In
support of these observations, neither cytochrome c re-
lease nor the apoptotic response was affected by the addi-
tion of uncouplers that dissipate DCm and thereby pre-
vent any hyperpolarization (Fig. 6). Indeed, the presence
of these uncouplers in no way affected the function of
proapoptotic or antiapoptotic Bcl-2 family members (Fig.
7). These data preclude a requirement for large-scale
changes (either an increase or decrease) in DCm as a gen-
eral mechanism for mitochondrial outer membrane per-
meabilization during apoptosis.
Although there were no significant changes in DCm be-
fore cytochrome c release, in our single-cell experiments
we observed a caspase-independent loss of DCm shortly
after cytochrome c release (Fig. 3). The loss of DCm after
cytochrome c release that we observed in single-cell analy-
sis appeared to contrast with our results obtained by bulk
cell analysis, which showed that DCm was maintained af-
ter cytochrome c release (Fig. 1; Bossy-Wetzel et al.,
1998). This paradox was resolved by the observation that
in the presence of a caspase inhibitor or in the absence of
Apaf-1 (which prevents caspase activation through the ap-
Figure 7. Bcl-2 family members maintain their proapoptotic and antiapoptotic functions in the presence of uncouplers of DCm. (A)
Confocal micrographs of immunocytochemistry of Bax (left) in Cc-GFP-HeLa cells treated with UV (180 mJ/cm2) for 6 h in the absence
(top) or presence (bottom) of FCCP (5 mM). Cytochrome c–GFP fluorescence (right) in the same cells is also shown. (B) Permeabilized
HeLa cells were treated with tBid (20 mg/ml) or Bax (10 mg/ml) in the absence (left) or presence (right) of FCCP (5 mM). Cytochrome
c–GFP fluorescence was detected by flow cytometry in FL-1. Release of cytochrome c–GFP was observed as a drop in overall fluores-
cence in the cells. (C) Cc-GFP-HeLa cells, which overexpress Bcl-2, were treated with UV (180 mJ/cm2) in the presence or absence of
FCCP (5 mM), CCCP (10 mM), or DNP (800 mM). Cells were harvested after 6 h and assayed for phosphatidylserine exposure or cyto-
chrome c–GFP release. The extent of annexin V binding and cytochrome c–GFP release was compared with cells that did not express
Bcl-2, which were treated with UV at the same time. Bars, 20 mm.Waterhouse et al. Mitochondrial Function in Apoptosis 327
optosome), DCm regenerated during the 60 min after cy-
tochrome c release and sustained subsequently (Fig. 4).
Since permeabilization of the mitochondrial outer mem-
brane occurs at different times in different cells, this loss
and recovery of DCm appears as an overall maintenance
of DCm at the bulk cell level.
We found that after cytochrome c release, the DCm was
maintained by the electron transport chain rather than by
reversal of the ATP synthase (Fig. 4). In digitonin-treated
cells, 10 mM cytochrome c was sufficient to maintain elec-
tron transport after permeabilization of the mitochondrial
outer membrane during apoptosis (Fig. 2). We calculated
that, if cytochrome c was evenly dispersed throughout the
Cc-GFP-HeLa cells, it would result in a concentration of
z10 mM. This is consistent with previous estimations that
the concentration of cytochrome c in the intermembrane
space is between 0.5 and 5 mM (Forman and Azzi, 1997).
Since the intermembrane space represents z10% of the
mitochondria and mitochondria can occupy 10–30% of the
total cell volume, we can estimate that the final concentra-
tion of cytochrome c throughout a cell would range be-
tween 5 and 150 mM.
Although there is sufficient cytochrome c to maintain
DCm after permeabilization of the mitochondrial outer
membrane, we observe a transient depolarization that then
recovers in the absence of caspase activity. The mechanism
of this depolarization is unknown. One possibility is based
on changes in respiration in response to ADP. At high ADP
concentrations, mitochondria increase respiration (state 3),
resulting in a decrease in DCm. As the ADP is converted to
ATP, the ratio of ADP/ATP decreases, and mitochondria
enter state 4, with decreased respiration and increased DCm.
Therefore, the drop in DCm we observe after cyto-
chrome c release may represent a shift from state 4 to 3 res-
piration, induced by a sudden increase in ADP/ATP. This
would be followed by an increase in DCm as the ADP is
converted to ATP. This is consistent with a model suggest-
ing that the voltage-dependent anion channel closes dur-
ing apoptosis, and therefore ATP accumulates in the mi-
tochondria, whereas ADP accumulates in the cytosol
(Vander Heiden et al., 1999, 2000). Upon outer membrane
permeabilization, ADP levels at the mitochondria would
therefore suddenly increase. However, for these transitions
to state 3 and 4 to occur, both electron transport and the
function of the F0/F1 ATPase are required. Since oligomy-
cin, which inhibits the F0/F1 ATPase, had no effect on ei-
ther the drop or recovery of DCm after cytochrome c
release (Fig. 4), this explanation is unlikely. Another possi-
bility is a transient opening of the adenosine nucleotide
translocator, which temporarily dissipates DCm. However,
cyclosporin A (#400 mM), which delays adenosine nucle-
otide translocator opening (Crompton et al., 1998), had no
effect on the kinetics or extent of the depolarization or the
recovery of DCm after cytochrome c release (data not
shown). A third possibility is that the decrease in cyto-
chrome c concentration results in a transient production of
reactive oxygen species that temporarily disrupt electron
transport. Cytochrome c, at the high levels found in mito-
chondria, is a potent antioxidant (Forman and Azzi, 1997),
and this effect may be compromised as the levels drop
upon outer membrane permeabilization.
Although we do not know the underlying mechanism of
this DCm depolarization, the effects of temperature on this
phenomenon are potentially informative. We have previ-
ously reported that the release of cytochrome c from the mi-
tochondria is rapid and temperature independent. That is,
reduction of the temperature to 248C did not affect the in-
terval between initial and complete release of cytochrome c
(Goldstein et al., 2000). However, we found that dissipation
of DCm to 10% of initial levels in cells incubated at 248C
took more than twice as long as cells incubated at 378C. This
prolonged kinetics suggests that temperature-dependent
enzymatic effects are involved in the process by which DCm
is lost but do not play a role in cytochrome c release.
In addition to maintenance of DCm, we found that in
the absence of caspase activation ATP synthesis by the mi-
tochondria (i.e., oligomycin-sensitive maintenance of ATP
levels) continues in cells despite mitochondrial outer
membrane permeabilization (Fig. 5). These data show that
even though the outer mitochondrial membrane has been
permeabilized, the mitochondrial inner membrane re-
mains intact, the electron transport chain and ATP syn-
thase remain functional, and the cytochrome c within the
cytosol is sufficient to drive oxidative phosphorylation.
These conclusions are supported by previous studies that
show that isolated mitochondria treated with tBid main-
tain their ability to import protein after cytochrome c re-
lease (von Ahsen et al., 2000).
Various aspects of mitochondrial metabolism have been
reported to impact on the apoptotic process. Apoptosis is
an active (ATP-requiring) process and, if sufficient ATP is
not present, the cell death deviates from an apoptotic to a
necrotic phenotype (Eguchi et al., 1997; Nicotera et al.,
1998). The proton gradient across the mitochondrial inner
membrane is essential for the production of ATP via oxi-
dative phosphorylation, and a reduction in this gradient
will impact on the potential of the cell to produce ATP
and survive. Recent studies have reported that sympa-
thetic neurons can be rescued from caspase-independent
cell death, even after mitochondrial outer membrane per-
meabilization and cytochrome c release, however, recov-
ery was not possible after DCm had dissipated (Deshmukh
et al., 2000). Similarly, we observe an eventual loss of
DCm even in the presence of caspase inhibitors, and this
precedes a drop in ATP and death of the cell (Fig. 5; data
not shown). Before this drop, however, it remains possible
that during the period over which DCm is maintained,
nonneuronal cells may have the potential to recover after
cytochrome c release. This is consistent with the recent ob-
servations that defects in Apaf-1 or caspase-9, which
should act downstream of mitochondrial outer membrane
permeabilization, can contribute to oncogenic transforma-
tion (Soengas et al., 1999).
In conclusion, our results suggest that before or in the
absence of caspase activation, mitochondria can maintain
several functions, including the generation of ATP, and
may contribute to survival of the cells for prolonged peri-
ods after cytochrome c release.
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